Skip to main content

Table 3 Antigenicity prediction using the Kolaskar and Tongaonkar technique

From: Immunoinformatics approach to epitope-based vaccine design against the SARS-CoV-2 in Bangladeshi patients

Start

End

Peptide

Length

223

233

YSLEFQSFGW

10

314

322

YMSLGPMVL

9

812

820

YLVPCYTCL

9

301

310

YYKLVPFWSF

10

962

970

YWQNSRLTF

9

590

598

YSLEFQSFGW

10

148

156

YLVPCYTCL

9

92

101

WWLLPVIVEV

10

448

456

WTAGAAAYY

9

193

201

WLLPVIVEV

9

130

139

SIFGCLLPQK

10